Subsidies & Funding

We empower medical innovation

Project Management

We manage your EU Horizon 2020 project

Business Strategy

We support successful commercialisation

Funding database

EU & non EU subsidies

News

Select your Innovative Medicines Initiative (IMI) opportunity now!

September 20 2016

The Innovative Medicines Initiative (IMI) is the world's biggest public-private partnership (PPP) in the life sciences. Through the IMI 2 programme, it has a €3.3 billion budget for the period 2014-2024. The new calls for proposals are expected to be launched this Autumn. Preparation is everything, so select the right opportunity now!

The aim of IMI is to improve health by speeding up the development of, and patient access to, innovative medicines. To submit a successful project, you will need to form a consortium consisting of the “key” players involved in healthcare research, including universities, the pharmaceutical and other industries, small and medium-sized enterprises (SMEs), patient organisations, and medicines regulators. Then, apply for support in response to an open Call for proposals.

The following topics are under consideration for inclusion in Calls for proposals to be launched in Autumn 2016:

At ttopstart we are specialised in forming complementary consortia consisting of key players in healthcare with a competitive edge. We serve leading researchers and innovative companies exclusively in the fields of life sciences, medical technology and health in more than 20 European countries and the US and Canada by acquiring funding for cutting-edge research and development. Are you thinking about submitting a proposal to IMI and do you want support in developing a competitive proposal? Feel free to contact us to discuss your possibilities.

All information regarding future IMI Call topics is indicative and subject to change. Final information about future IMI Calls will be communicated after approval by the IMI Governing Board.

Share this